Where does Surgimatix, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Surgimatix, Inc. ranks #23,484 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Surgimatix, Inc. hold?

Surgimatix, Inc. holds 12 US utility patents granted between 2016 and 2019, spanning 2 technology areas.

What is Surgimatix, Inc.'s Innovation Score?

Surgimatix, Inc. has an Innovation Score of 25.5 out of 100 (18th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Surgimatix, Inc. focus on?

Surgimatix, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 12 patents, ranking #1,451 of 7,127 assignees active in that subclass. Grants appear in 2 CPC subclasses total.

Is Surgimatix, Inc.'s patent grant rate increasing or decreasing?

Surgimatix, Inc.'s recent grant velocity is -100% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Surgimatix, Inc.'s patents?

Surgimatix, Inc.'s patents average 19.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Surgimatix, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Surgimatix, Inc.

USPTO PatentsView assignee record - 12 granted patents across 2 technology areas, recorded in grant years 2016–2019. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Surgimatix ranks #23,484 of 49,997 tracked US assignees by granted-patent volume, with 12 patents across 2 technology areas.

#23,484
of 49,997 US assignees by volume: 18th percentile
by Innovation Score (25.5/100): 19.4
avg claims per patent: -100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R23484 · US Corporation #23,484 · 12 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 12 grants
MID-PACK #23,484/49,997
PHOTO-FINISH Sumitomo Dainippon…
CPC-NARROW A61B · 2 areas
INNOV-THIN 25.5/100
CLAIMS-RICH 19.4 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Sumitomo Dainippon Pharma Oncology, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Surgimatix’s 25.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.9 pts (35%) Velocity 0.0 pts (0%) Breadth 5.0 pts (20%) Claim depth 11.7 pts (46%)

Qualcomm Incorporated · highest

85
Art Design Works · near

26
Ipee · near

26
Tuper S/A · near

26
Surgimatix · this assignee

26
CSG Systems · near

26
3D Lighting… · lowest

7

What this shows Surgimatix's Innovation Score is 25.5/100 (18th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Surgimatix?

Each dot is one of Surgimatix’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Surgimatix’s own 19.4 claims/patent is ABOVE the 14.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Surgimatix vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Surgimatix's grants concentrate

Surgimatix, Inc. is a focused PatentsView assignee: 2 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2018 (5 grants) versus a trough of 1 in 2016. By volume, Surgimatix sits between Sumitomo Dainippon Pharma Oncology, Inc. and Symbolic LLC.

Sumitomo Dainippo…

12
Sundrop Fuels

12
Superb AI

12
Surfacide

12
Suzhou Institute…

12
Swirlds

12
Sy Kessler Sales

12
Symbolic

12
Surgimatix ◀

12

What this shows Surgimatix holds 12 patents at rank #23,480, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Surgimatix

By rank, the assignees closest to #23,480 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Surgimatix's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Surgimatix, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Surgimatix ranks #1,451 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (26 here).

Tuper S/A 26 Ipee NV 26 CSG Systems, Inc. 26 Art Design Works LLC 26

Surgimatix's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

26 18th percentile higher than 18% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2019

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Surgimatix, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	8.3%
2017	2	16.7%
2018	5	41.7%
2019	4	33.3%

Which technologies does Surgimatix, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 12

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 3

Top 2 of 2 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Surgimatix, Inc.'s patent record in context - here's where to go next.

Surgimatix, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #23,484 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Surgimatix, Inc. against Sumitomo Dainippon Pharma Oncology, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 25.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.